Terms: = Endocrine gland cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Clinical Outcome
5 results:
1. Improving Gemcitabine Sensitivity in Pancreatic cancer Cells by Restoring miRNA-217 Levels.
Panebianco C; Trivieri N; Villani A; Terracciano F; Latiano TP; Potenza A; Perri F; Binda E; Pazienza V
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33925948
[TBL] [Abstract] [Full Text] [Related]
2. Progesterone Receptor Isoforms A and B in Pancreatic Neuroendocrine Tumor.
Yazdani S; Kasajima A; Ogata H; Felizola SJ; Nakamura Y; Onodera Y; Watanabe M; Motoi F; Unno M; Sasano H
Neuroendocrinology; 2015; 101(4):309-20. PubMed ID: 25791399
[TBL] [Abstract] [Full Text] [Related]
3. Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors.
Colli LM; Saggioro F; Serafini LN; Camargo RC; Machado HR; Moreira AC; Antonini SR; de Castro M
PLoS One; 2013; 8(4):e62424. PubMed ID: 23638078
[TBL] [Abstract] [Full Text] [Related]
4. Cyclin D1 (ccnd1) genotype is associated with tumour grade in sporadic pituitary adenomas.
Simpson DJ; Fryer AA; Grossman AB; Wass JA; Pfeifer M; Kros JM; Clayton RN; Farrell WE
Carcinogenesis; 2001 Nov; 22(11):1801-7. PubMed ID: 11698342
[TBL] [Abstract] [Full Text] [Related]
5. Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells.
Dhar KK; Branigan K; Parkes J; Howells RE; Hand P; Musgrove C; Strange RC; Fryer AA; Redman CW; Hoban PR
Br J Cancer; 1999 Dec; 81(7):1174-81. PubMed ID: 10584879
[TBL] [Abstract] [Full Text] [Related]
